China Biologic Products (CBPO) Reports Q4 EPS of $0.76/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Caribou Biosciences to halt CAR-T programs, explore sale
- Emera and Canadian Utilities agree to merge in $72B all-share deal
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018
March 6, 2019 5:00 PM EST-- 4Q18 Total Sales Up 27.5% YoY in USD terms, or 33.5% YoY in RMB terms;Net Income Up $59.4 Million YoY to $34.8 Million;Non-GAAP Adjusted Net Income Up 23.9% YoY in RMB terms --
-- FY18 Total Sales Up 26.1% YoY in USD terms, or 23.5% YoY in RMB terms;Net Income Up 88.7% YoY to $128.1 Million; Non-GAAP Adjusted Net Income Up 0.6% YoY in RMB terms --
-- Issues Forecast for FY19 --
-- Board of Directors Extends previously Approved Share Repurchase Program --
BEIJING,... More



